Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
2,321 to 2,340 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prognostic Value of Genomic Instability of m6A-Related lncRNAs in Lung Adenocarcinoma. | Front Cell Dev Biol | 2022 | 35309906 | PubTator, text mining | PubMed |
| N6-Methyladenosine Modification Participates in the Progression of Hepatitis B Virus-Related Liver Fibrosis by Regulating Immune Cell Infiltration. | Front Med (Lausanne) | 2022 | 35308519 | PubTator, text mining | PubMed |
| METTL14-mediated N6-methyladenosine modification of ITGB4 mRNA inhibits metastasis of clear cell renal cell carcinoma. | Cell Commun Signal | 2022 | 35305660 | PubTator, text mining | PubMed |
| WTAP-mediated m6A modification of lncRNA NORAD promotes intervertebral disc degeneration. | Nat Commun | 2022 | 35304463 | PubTator, text mining | PubMed |
| N6-methyladenosine-related lncRNAs is a potential marker for predicting prognosis and immunotherapy in ovarian cancer. | Hereditas | 2022 | 35303965 | PubTator, text mining | PubMed |
| M6A RNA Methylation Regulates Histone Ubiquitination to Support Cancer Growth and Progression. | Cancer Res | 2022 | 35303054 | PubTator, text mining | PubMed |
| Interactions of circRNAs with methylation: An important aspect of circRNA biogenesis and function (Review). | Mol Med Rep | 2022 | 35302170 | PubTator, text mining | PubMed |
| Development and Validation of a Ferroptosis-Related lncRNAs Prognosis Model in Oral Squamous Cell Carcinoma. | Front Genet | 2022 | 35299954 | PubTator, text mining | PubMed |
| FTO promotes colorectal cancer progression and chemotherapy resistance via demethylating G6PD/PARP1. | Clin Transl Med | 2022 | 35297218 | PubTator, text mining | PubMed |
| Targeting the RNA m6A modification for cancer immunotherapy. | Mol Cancer | 2022 | 35296338 | PubTator, text mining | PubMed |
| An Overview of Epigenetic Methylation in Pancreatic Cancer Progression. | Front Oncol | 2022 | 35296007 | PubTator, text mining | PubMed |
| Targeted Manipulation of Cellular RNA m6A Methylation at the Single-Base Level. | ACS Chem Biol | 2022 | 35294178 | PubTator, text mining | PubMed |
| Use of High-Performance Liquid Chromatography-Mass Spectrometry (HPLC-MS) to Quantify Modified Nucleosides. | Methods Mol Biol | 2022 | 35290635 | PubTator, text mining | PubMed |
| FMRP promotes transcription-coupled homologous recombination via facilitating TET1-mediated m5C RNA modification demethylation. | Proc Natl Acad Sci U S A | 2022 | 35290126 | PubTator, text mining | PubMed |
| m6A RNA modifications are measured at single-base resolution across the mammalian transcriptome. | Nat Biotechnol | 2022 | 35288668 | PubTator, text mining | PubMed |
| METTL3 modulates m6A modification of CDC25B and promotes head and neck squamous cell carcinoma malignant progression. | Exp Hematol Oncol | 2022 | 35287752 | PubTator, text mining | PubMed |
| Advanced glycation end products alter the m6A-modified RNA profiles in human dermal fibroblasts. | Epigenomics | 2022 | 35285253 | PubTator, text mining | PubMed |
| Methyltransferase-like 3 upregulation is involved in the chemoresistance of non-small cell lung cancer. | Ann Transl Med | 2022 | 35284536 | PubTator, text mining | PubMed |
| Modification of STIM2 by m6A RNA methylation inhibits metastasis of cholangiocarcinoma. | Ann Transl Med | 2022 | 35282134 | PubTator, text mining | PubMed |
| The methylation modification of m6A regulators contributes to the prognosis of ovarian cancer. | Ann Transl Med | 2022 | 35282121 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=117